Status:
COMPLETED
Efficacy and Safety of Meloxicam (Mobicox®) in Mexican Population With Rheumatic Diseases
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Osteoarthritis
Eligibility:
All Genders
12+ years
Brief Summary
Study to evaluate the efficacy and safety of meloxicam (Mobicox®) in Mexican population with rheumatic diseases.
Eligibility Criteria
Inclusion
- none
Exclusion
- Hypersensitivity to meloxicam or to other NSAIDS
- History of asthma, angioedema or urticaria secondary to NSAIDS
- Pregnancy or lactation
- Recent or current history of peptic ulcer disease, severe renal failure, severe hepatic failure
- Age below of 12 years.
Key Trial Info
Start Date :
May 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
12687 Patients enrolled
Trial Details
Trial ID
NCT02184039
Start Date
May 1 2003
Last Update
July 9 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.